Niagen Bioscience Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: NAGE
Share price (7/22/26): $3.40
Market cap (7/22/26): $270 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-Q 3 pages Amendment to Asset Purchase Agreement

from 10-Q 67 pages Asset Purchase Agreement by and Among Covance Laboratories Inc., Chromadex, Inc., Chromadex Analytics, Inc., and Chromadex Corporation Dated August 21, 2017

from SC 13D/A 1 page Irrevocable Proxy Proxy Holder Proxy Shares Frank Louis Jaksch, Jr. 1,429,000

from SC 13D/A 1 page Irrevocable Proxy Proxy Holder Proxy Shares Frank Louis Jaksch, Jr. 1,429,000

from 8-K 47 pages Agreement and Plan of Merger by and Among Cody Resources, Inc., CDI Acquisition, Inc. and Chromadex, Inc. May 21, 2008

from 8-K 3 pages Agreement of Merger by and Between Cody Resources, Inc. (A Nevada Corporation) and Cody Resources, Inc